DE69735760D1 - Antikörper gegen menschliches lect2, zellen die diesen produzieren und verfahren und kit zu dessen bestimmung - Google Patents

Antikörper gegen menschliches lect2, zellen die diesen produzieren und verfahren und kit zu dessen bestimmung

Info

Publication number
DE69735760D1
DE69735760D1 DE69735760T DE69735760T DE69735760D1 DE 69735760 D1 DE69735760 D1 DE 69735760D1 DE 69735760 T DE69735760 T DE 69735760T DE 69735760 T DE69735760 T DE 69735760T DE 69735760 D1 DE69735760 D1 DE 69735760D1
Authority
DE
Germany
Prior art keywords
antibodies
kit
cells
determination
produce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69735760T
Other languages
English (en)
Other versions
DE69735760T2 (de
Inventor
Takao Arai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical and Biological Laboratories Co Ltd
Original Assignee
Medical and Biological Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical and Biological Laboratories Co Ltd filed Critical Medical and Biological Laboratories Co Ltd
Publication of DE69735760D1 publication Critical patent/DE69735760D1/de
Application granted granted Critical
Publication of DE69735760T2 publication Critical patent/DE69735760T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
DE69735760T 1996-05-27 1997-05-26 Antikörper gegen menschliches lect2, zellen die diesen produzieren und verfahren und kit zu dessen bestimmung Expired - Fee Related DE69735760T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP13216096 1996-05-27
JP13216096 1996-05-27
PCT/JP1997/001775 WO1997045451A1 (fr) 1996-05-27 1997-05-26 Anticorps anti-lect2 humains, cellules le produisant et ses procede et materiel de dosage

Publications (2)

Publication Number Publication Date
DE69735760D1 true DE69735760D1 (de) 2006-06-01
DE69735760T2 DE69735760T2 (de) 2007-05-10

Family

ID=15074775

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69735760T Expired - Fee Related DE69735760T2 (de) 1996-05-27 1997-05-26 Antikörper gegen menschliches lect2, zellen die diesen produzieren und verfahren und kit zu dessen bestimmung

Country Status (6)

Country Link
US (1) US6306608B1 (de)
EP (1) EP0908466B1 (de)
JP (1) JP3888695B2 (de)
AU (1) AU725682B2 (de)
DE (1) DE69735760T2 (de)
WO (1) WO1997045451A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4378439B2 (ja) * 1998-12-22 2009-12-09 国立感染症研究所長 骨吸収抑制剤
EP1482973B1 (de) 2002-03-15 2009-08-19 Schering Corporation Verfahren zur modulierung von cd200-rezeptoren
CN102552882A (zh) * 2011-12-22 2012-07-11 宁波大学 Lect2蛋白及lect2蛋白变体在制药中应用
CN110646615B (zh) * 2019-08-27 2021-07-13 南方医科大学 肝纤维化的生物学标志物、治疗靶点及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3637087B2 (ja) 1994-11-28 2005-04-06 和男 鈴木 新規な白血球活性化因子

Also Published As

Publication number Publication date
AU725682B2 (en) 2000-10-19
EP0908466A4 (de) 2003-03-12
EP0908466B1 (de) 2006-04-26
JP3888695B2 (ja) 2007-03-07
US6306608B1 (en) 2001-10-23
AU2793297A (en) 1998-01-05
DE69735760T2 (de) 2007-05-10
EP0908466A1 (de) 1999-04-14
WO1997045451A1 (fr) 1997-12-04

Similar Documents

Publication Publication Date Title
PT994865E (pt) Compostos de triazol e sua utilizacao como ligantes de dopamina-d3
PT1028954E (pt) Imidazoles substituidos uteis no tratamento de doencas inflamatorias
ID23687A (id) Metode penggunaan penghambat siklooksigenase-2 dalam pencegahan penyakit kardiovaskuler
DE69730259D1 (de) Schichtstoff und Verfahren zu dessen Herstellung
DE69513919D1 (de) Sprachanalyse
DE1017332T1 (de) Anwendungverfahren in dentaler artikulation
PT891426E (pt) Bicunina humana
DE69531399D1 (de) Kunstherz
FI962055A (fi) Pariston jatkolaite ja siihen liittyvä menetelmä
DE69620818D1 (de) Menschliche Muskelkraft unterstützender Energie-Wandler
ATE317010T1 (de) Krankheitsresistenz in vitis
ID22053A (id) Turunan asam aminofosfonat dalam sediaan farmasi
DE19881702D2 (de) Cuff-Elektrode und Verfahren zu deren Herstellung
DE69636710D1 (de) Festelektrolytkondensator und dessen herstellungsverfahren
DE69703149D1 (de) Gebrauchtsfertiges metalldraht und verfahren zu dessen herstellung
DE69737627D1 (de) Analysezelle
DE69735760D1 (de) Antikörper gegen menschliches lect2, zellen die diesen produzieren und verfahren und kit zu dessen bestimmung
ID17052A (id) Turunan-turunan asam asetat terapeutik
FI972253A0 (fi) Sienimuotoisen aivosairauden defektiomenetelmät
DE69516534T2 (de) Antikörper gegen allogene und xenogene proteine, ihre verwendung in diagnose und therapie und verfahren zu ihrer bestimmung
FI972254A0 (fi) Sienimuotoisen aivosairauden defektiomenetelmät
DE3785637D1 (de) Monoklonale antikoerper gegen menschliche mesotheliale zellen.
DE59704041D1 (de) Verbundkörper und verfahren zu seiner herstellung
FR2735470B1 (fr) Nitrocetones et nitroximes, leur preparation et leur application en therapeutique
DE29503674U1 (de) Zerlegbarer Patienten-Lothublifter in Leichtausführung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee